| | 
Part, Chapter, Paragraph
1 II, 6.Acr | Tick-Borne Encephalitis~VCJD~Variant Creutzfeldt-Jakob disease~
2 II, 6. 3. 3| ratio, 1.5:1).~ ~A specific variant of the bacteria, lymphogranuloma
3 II, 6. 3. 6| 3.6.4. Prion diseases~ ~Variant Creutzfeldt-Jakob disease (
4 II, 6. 3. 6| Creutzfeldt-Jakob disease (vCJD)~ ~Variant Creutzfeldt-Jakob disease (
5 II, 6. 3. 6| of a future outbreak of variant CJD in the UK and in other
6 III, 10. 2. 1| counter advertising (a variant of public information campaigns
7 III, 10. 2. 4| the concept of a genomic variant being in individuals a risk
8 III, 10. 2. 4| of G-308A TNF alpha gene variant in obesity, asthma and non-Hodgkin
9 III, 10. 2. 4| genetic test” to “genomic variant” to “genome-based health
10 III, 10. 2. 4| necrosis factor alpha gene variant and phenotypes associated
11 III, 10. 3. 3| Haemophilus influenzae type b~vCJD~Variant Creutzfeldt-Jakob disease~ ~ ~
12 III, 10. 3. 3| characteristic symptoms.~ ~Prions~ ~Variant Creutzfeldt-Jakob disease (
13 IV, 11. 5. 6| possible transmission of variant Creutzfeldt-Jakob Disease (
14 IV, 12. 2 | counter advertising (a variant of public information campaigns
|
|
| |
